OnabotulinumtoxinA 100 UNT [Botox]

DRUG4 trials

Sponsors

University Of Perugia, University of California, Irvine, Women and Infants Hospital of Rhode Island, Stanford University

Conditions

Overactive BladderOveractive Bladder SyndromeTrigeminal NeuralgiaUrge IncontinenceUrgency Urinary IncontinenceUrinary FrequencyUrinary Incontinence, UrgeUrinary Urge Incontinence

Phase 3

Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin

University Of PerugiaOveractive Bladder Syndrome

Start: 2018-09-01End: 2021-09-01Updated: 2020-11-06

Phase 4

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial

CompletedNCT05308979

University of California, IrvineOveractive Bladder, Overactive Bladder Syndrome, Urge Incontinence +4

Start: 2022-05-01End: 2024-03-31Updated: 2026-02-25

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

Active, not recruitingNCT05806164

Women and Infants Hospital of Rhode IslandUrgency Urinary Incontinence

Start: 2023-06-06End: 2030-08-01Target: 432Updated: 2026-06-29

OnabotulinumtoxinA for Trigeminal Neuralgia

RecruitingNCT06216886

Stanford UniversityTrigeminal Neuralgia

Start: 2024-06-01End: 2027-09-01Target: 20Updated: 2026-01-22